Products
Online Inquiry
Our Products Cannot Be Used As Medicines Directly For Personal Use.
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.
WYE-125132
Cat No.
CEI-0106
Description
WYE-125132
CAS No.
1144068-46-1
Molecular Weight
519.6
Purity
>99%
Storage
2 years at -20 centigrade
Targets
mTOR
Molecular Formula
C27H33N7O4
Solubility
No
In vitro
As an ATP-competitive inhibitor, WYE-125132 can potently inibit mTOR with IC50 of 0.19 nM. And WYE-125132 shows >5,000-fold selective versus PI3Ks. WYE-132 also can inhibit mTORC1 and mTORC2. WYE-132 targeted P-AKT(S473) and AKT function without significantly reducing the steady-state level of P-AKT(T308), which is the PI3K/PDK1 activity biomarker. WYE-132 shows stronger inhibition of cancer cells than that of temsirolimus. WYE-132 can inhibit cell growth and survival, protein synthesis, cell size, bioenergetic metabolism, and adaptation to hypoxia. Treatment of cancer cells with WYE-132 leads to a rapid loss of the phosphorylation at Ser-75. WYE-132-induced Maf1 dephosphorylation correlated with its accumulation in the nucleus and a marked decline in the cellular levels of pre-tRNAs.
Download
Download Datasheet